Immunology News and Research

Latest Immunology News and Research

Heavily congested highway correlates with higher rates of asthma

Researchers at SUNY Downstate Medical Center and Lutheran Medical Center in Brooklyn, New York, found that living near a heavily congested highway correlates with a higher presence of asthma.

27 Jun 2012

Simple blood test may help physicians track progression of RA disease activity

A simple blood test may help physicians track the progression of rheumatoid arthritis disease activity, say researchers at the University of Alabama at Birmingham.

27 Jun 2012

Seahorse Bioscience launches XF Palmitate-BSA FAO Reagent for FAO assays

Seahorse Bioscience, the world leader in manufacturing instrumentation and assay kits for measuring cellular metabolism, has announced the launch of its newest product, the XF Palmitate-BSA FAO Reagent, eliminating the need for radioactivity in fatty acid oxidation (FAO) assays.

27 Jun 2012

SCRI receives NIH grant for Science Adventure Lab program

Over the past three years, more than 20,000 students at 135 schools in Washington State have participated in the Science Adventure Lab program, an initiative launched by Seattle Children's Research Institute in 2009.

26 Jun 2012

Exposure to BBzP during pregnancy can increase risk of eczema in children

Prenatal exposure to a ubiquitous household chemical called butylbenzyl phthalate (BBzP) can increase a child's risk for developing eczema, according to research conducted at the Columbia Center for Children's Environmental Health at the Mailman School of Public Health.

26 Jun 2012

Some caregivers unsure about when to give epinephrine for children with food allergies

Young children with allergies to milk and egg experience reactions to these and other foods more often than researchers had expected, a study reports. The study also found that severe and potentially life-threatening reactions in a significant number of these children occur and that some caregivers are hesitant to give such children epinephrine, a medication that reverses the symptoms of such reactions and can save lives.

26 Jun 2012

Merck Serono, Compugen announce establishment of Neviah Genomics

Merck Serono, a division of Merck, Darmstadt, Germany, and Compugen Ltd. today announced the establishment of Neviah Genomics, a novel start-up company focused on the discovery and development of novel biomarkers for the prediction of drug-induced toxicity.

26 Jun 2012

Affymetrix acquires eBioscience

Affymetrix Inc., today announced that the Company has completed its acquisition of eBioscience Holding Company, Inc., a privately-held company with an industry-leading position in flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics.

26 Jun 2012

Uncontrolled symptoms of pediatric asthma found in 50% of children

Asthma is a serious disease that when left undertreated, can be deadly. In fact, asthma accounts for 4,000 deaths annually in the United States alone. And according to a new International Consensus (ICON) on Pediatric Asthma, an alarming 50 percent of children worldwide have uncontrolled symptoms, despite today's available treatments.

25 Jun 2012

Study reinforces importance of educating parents and other caregivers of children with food allergy

A team of researchers from Mount Sinai School of Medicine and four other institutions have found that young children with documented or likely allergies to milk and/or eggs, whose families were instructed on how to avoid these and other foods, still experienced allergic reactions at a rate of almost once per year. Of severe cases, less than a third received epinephrine, a medication used to counter anaphylaxis, a life-threatening allergic condition.

25 Jun 2012

WCMC researchers devise innovative boxer-like strategy to fight multiple myeloma

Weill Cornell Medical College researchers have devised an innovative boxer-like strategy, based on the serial use of two anti-cancer drugs, to deliver a one-two punch to first weaken the defenses of multiple myeloma and then deliver the final knock-out punch to win the fight.

23 Jun 2012

Researchers identify new virus alert signal that triggers the human immune system

Researchers from Aarhus University have now located the place in the human body where the earliest virus alert signal triggers the human immune system. They have also discovered a new alarm signal, which is activated at the very first sign of a virus attack.

23 Jun 2012

Janssen receives FDA complete response letter for XARELTO sNDA

Janssen Research & Development, LLC (Janssen R&D) announced today the U.S. Food and Drug Administration (FDA) issued a complete response letter regarding a supplemental New Drug Application (sNDA) for XARELTO (rivaroxaban) for the reduction of the risk of secondary cardiovascular events in patients with acute coronary syndrome (ACS).

22 Jun 2012

International Consensus on Pediatric Asthma launches in Geneva

The International Consensus (ICON) on Pediatric Asthma has been launched during the EAACI Congress 2012 in Geneva. The goal of this ICON is to highlight the key messages that are common to many of the existing guidelines, while critically reviewing and commenting on their differences, thus providing a concise reference. The Pediatric Asthma ICON provides advice for the best clinical practice in pediatric asthma management.

21 Jun 2012

Omega-3 fatty acid supplements can reduce inflammation in overweight older adults

New research shows that omega-3 fatty acid supplements can lower inflammation in healthy, but overweight, middle-aged and older adults, suggesting that regular use of these supplements could help protect against and treat certain illnesses.

21 Jun 2012

Antimicrobial exposure may increase risk of allergies in children

Exposure to common antibacterial chemicals and preservatives found in soap, toothpaste, mouthwash and other personal-care products may make children more prone to a wide range of food and environmental allergies, according to new research from Johns Hopkins Children's Center.

20 Jun 2012

AstraZeneca, Rigel enter global license agreement for R256 inhaled JAK inhibitor to treat chronic asthma

AstraZeneca and Rigel Pharmaceuticals Inc. today announced an exclusive worldwide license agreement for the global development and commercialization of R256, Rigel's inhaled JAK inhibitor shown to inhibit IL-13 and IL-4 signalling, which is being investigated as a treatment for moderate to severe chronic asthma. In preclinical research, R256 has been shown to reduce airway inflammation and improve lung function.

19 Jun 2012

RayBiotech, Institute for Cancer Research collaborate to implement antibody-based sample analysis

RayBiotech, Inc. and the combined genotyping core facility for Oslo University Hospital and the University of Oslo, located at the Institute for Cancer Research, announced the execution of an agreement to collaborate for the implementation of antibody-based sample analysis services.

19 Jun 2012

Allergy risk in children linked to antibacterials in personal-care products

Exposure to common antibacterial chemicals found in soap, toothpaste, mouthwash and other personal-care products may make children more prone to a wide range of food and environmental allergies, according to new research from Johns Hopkins Children’s Center.

19 Jun 2012

New clues to why some urinary tract infections recur persistently

Scientists at Washington University School of Medicine in St. Louis have found new clues to why some urinary tract infections recur persistently after multiple rounds of treatment.

19 Jun 2012

Immunology News and Research

Latest Immunology News and Research

Heavily congested highway correlates with higher rates of asthma

Simple blood test may help physicians track progression of RA disease activity

Seahorse Bioscience launches XF Palmitate-BSA FAO Reagent for FAO assays

SCRI receives NIH grant for Science Adventure Lab program

Exposure to BBzP during pregnancy can increase risk of eczema in children

Some caregivers unsure about when to give epinephrine for children with food allergies

Merck Serono, Compugen announce establishment of Neviah Genomics

Affymetrix acquires eBioscience

Uncontrolled symptoms of pediatric asthma found in 50% of children

Study reinforces importance of educating parents and other caregivers of children with food allergy

WCMC researchers devise innovative boxer-like strategy to fight multiple myeloma

Researchers identify new virus alert signal that triggers the human immune system

Janssen receives FDA complete response letter for XARELTO sNDA

International Consensus on Pediatric Asthma launches in Geneva

Omega-3 fatty acid supplements can reduce inflammation in overweight older adults

Antimicrobial exposure may increase risk of allergies in children

AstraZeneca, Rigel enter global license agreement for R256 inhaled JAK inhibitor to treat chronic asthma

RayBiotech, Institute for Cancer Research collaborate to implement antibody-based sample analysis

Allergy risk in children linked to antibacterials in personal-care products

New clues to why some urinary tract infections recur persistently

eBook: The Ultimate Guide to Successful Immunofluorescence eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production